Filing Details
- Accession Number:
- 0001493152-24-021176
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-23 17:07:18
- Reporting Period:
- 2024-05-17
- Accepted Time:
- 2024-05-23 17:07:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1708599 | Serina Therapeutics Inc. | SER | Pharmaceutical Preparations (2834) | 821436829 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2008741 | Steven Mintz | 601 Genome Way, Suite 2001 Huntsville AL 35806 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-17 | 554 | $8.50 | 554 | No | 4 | P | Indirect | By Spouse |
| Common Stock | Acquisiton | 2024-05-20 | 195 | $9.48 | 749 | No | 4 | P | Indirect | By Spouse |
| Common Stock | Acquisiton | 2024-05-21 | 6,651 | $10.00 | 7,400 | No | 4 | P | Indirect | By Spouse |
| Common Stock | Acquisiton | 2024-05-21 | 2,500 | $9.75 | 9,900 | No | 4 | P | Indirect | By Spouse |
| Common Stock | Acquisiton | 2024-05-20 | 1,240 | $9.44 | 1,240 | No | 4 | P | Indirect | By Adult Child 1 |
| Common Stock | Acquisiton | 2024-05-20 | 1,240 | $9.42 | 1,240 | No | 4 | P | Indirect | By Adult Child 2 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Spouse |
| No | 4 | P | Indirect | By Spouse |
| No | 4 | P | Indirect | By Spouse |
| No | 4 | P | Indirect | By Spouse |
| No | 4 | P | Indirect | By Adult Child 1 |
| No | 4 | P | Indirect | By Adult Child 2 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,307 | Direct |
Footnotes
- The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
- The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
- Number of securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.
Billionaire Hedge Funds
